Evidence map›Paper›PMID 35550628›Full record

ReviewDiabetology & metabolic syndrome2022

Advances in the study of OSA and diabetic foot.

Jiayu Lin, Hailing Song, Meihong Liang, Zeqiang Cai, Tan Chen, Zhenyu Lin, Jinying Zhang

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetology & metabolic syndrome, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jiayu LinDepartment of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China. 415794814@qq.com.
Hailing SongFujian Medical University, Fuzhou, 350100, China.
Meihong LiangFujian Medical University, Fuzhou, 350100, China.
Zeqiang CaiFujian Medical University, Fuzhou, 350100, China.
Tan ChenFujian Medical University, Fuzhou, 350100, China.
Zhenyu LinFujian Medical University, Fuzhou, 350100, China.
Jinying ZhangDepartment of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China.
Fujian Medical University · CN

Funding

Fujian Provincial Health Technology Project 2021TG014the startup fund for scientific research, Fujian Medical University 2018QH1105the startup fund for scientific research, Fujian Medical University 2020QH1122
6 · The paper itself

Abstract

Diabetic foot is one of the most serious and painful chronic complications of diabetic patients, especially elderly diabetic patients. It has a high rate of death, disability and amputation. Obstructive sleep apnea (OSA) is a treatable chronic sleep disorder. Existing evidence suggests that OSA may promote the development and delay the healing of diabetic foot, and continuous positive airway pressure therapy may promote the healing of ulcers. Therefore, in the multidisciplinary diagnosis and treatment of diabetes, cooperation with sleep medicine should be strengthened, and the basic and clinical research on diabetic foot combined with OSA should be strengthened, so as to reduce the amputation rate, improve the cure rate and reduce the incidence of cardiovascular events.

Indexed as

Diabetic complicationsDiabetic footObstructive sleep apneaPathogenesis

Identifiers

PMID35550628
PMCPMC9097179
OpenAlexW4280508640

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.